BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chang S, Cao Y. The ROCK inhibitor Y-27632 ameliorates blood-spinal cord barrier disruption by reducing tight junction protein degradation via the MYPT1-MLC2 pathway after spinal cord injury in rats. Brain Res 2021;1773:147684. [PMID: 34634287 DOI: 10.1016/j.brainres.2021.147684] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Jiang T, Qin T, Gao P, Tao Z, Wang X, Wu M, Gu J, Chu B, Zheng Z, Yi J, Xu T, Huang Y, Liu H, Zhao S, Ren Y, Chen J, Yin G. SIRT1 attenuates blood-spinal cord barrier disruption after spinal cord injury by deacetylating p66Shc. Redox Biol 2023;60:102615. [PMID: 36716673 DOI: 10.1016/j.redox.2023.102615] [Reference Citation Analysis]
2 Deng L, Lv JQ, Sun L. Experimental treatments to attenuate blood spinal cord barrier rupture in rats with traumatic spinal cord injury: A meta-analysis and systematic review. Front Pharmacol 2022;13:950368. [DOI: 10.3389/fphar.2022.950368] [Reference Citation Analysis]
3 Bagnell AM, Sumner CJ, McCray BA. TRPV4: A trigger of pathological RhoA activation in neurological disease. Bioessays 2022;:e2100288. [PMID: 35297520 DOI: 10.1002/bies.202100288] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]